These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


92 related items for PubMed ID: 11558073

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Paradoxical effects of anti-TNF-α agents in inflammatory diseases.
    Wendling D, Prati C.
    Expert Rev Clin Immunol; 2014 Jan; 10(1):159-69. PubMed ID: 24325385
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
    Egan LJ, Sandborn WJ, Tremaine WJ.
    Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
    [Abstract] [Full Text] [Related]

  • 11. Crohn's disease: an important differential diagnosis of granulomatous skin diseases.
    Eames T, Landthaler M, Karrer S.
    Eur J Dermatol; 2009 Mar; 19(4):360-4. PubMed ID: 19443301
    [Abstract] [Full Text] [Related]

  • 12. Influence of topically and systemically active steroids on circulating leukocytes in Crohn's disease.
    Tillinger W, Gasche C, Reinisch W, Lichtenberger C, Bakos S, Dejaco C, Moser G, Vogelsang H, Gangl A, Lochs H.
    Am J Gastroenterol; 1998 Oct; 93(10):1848-53. PubMed ID: 9772043
    [Abstract] [Full Text] [Related]

  • 13. Crohn's disease. Ultrastructural studies showing basophil leukocyte granule changes and lymphocyte parallel tubular arrays in peripheral blood.
    Dvorak AM, Monahan RA.
    Arch Pathol Lab Med; 1982 Mar; 106(3):145-9. PubMed ID: 6895842
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Methotrexate in Crohn's disease: results of a randomized, double-blind, placebo-controlled trial.
    Arora S, Katkov W, Cooley J, Kemp JA, Johnston DE, Schapiro RH, Podolsky D.
    Hepatogastroenterology; 1999 Mar; 46(27):1724-9. PubMed ID: 10430331
    [Abstract] [Full Text] [Related]

  • 17. Clinical features of Crohn's disease in Ireland.
    Fielding JF.
    Am J Gastroenterol; 1986 Jul; 81(7):524-8. PubMed ID: 3717112
    [Abstract] [Full Text] [Related]

  • 18. Acute gastrocnemius myositis. Another extraintestinal manifestation of Crohn's disease.
    Drabble EM, Gani JS.
    Med J Aust; 1992 Sep 07; 157(5):318-20. PubMed ID: 1435473
    [Abstract] [Full Text] [Related]

  • 19. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
    Charpignon C, Beau P.
    Gastroenterol Clin Biol; 2008 Feb 07; 32(2):153-7. PubMed ID: 18343615
    [Abstract] [Full Text] [Related]

  • 20. Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation.
    Jenkins D, Seth R, Kummer JA, Scott BB, Hawkey CJ, Robins RA.
    J Pathol; 2000 Feb 07; 190(2):184-9. PubMed ID: 10657017
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.